Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A D Lewis

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Biochemical Pharmacology|October 23, 1998
Reduction of the indoloquinone anticancer drug EO9 by purified DT-diaphorase: a detailed kinetic study and analysis of metabolitesS M Bailey, A D Lewis, R J Knox, et al.
Biochemical Pharmacology|July 13, 2001
Involvement of NADPH: cytochrome P450 reductase in the activation of indoloquinone EO9 to free radical and DNA damaging speciesS M Bailey, A D Lewis, L H Patterson, et al.
Biochemical Society Transactions|August 1, 1987
The role of glutathione in determining the response of normal and tumor cells to anticancer drugsC R Wolf, A D Lewis, J Carmichael, et al.
The Journal of Biological Chemistry|April 5, 1987
Induction and suppression of glutathione transferases by interferon in the mouseD J Adams, F R Balkwill, D B Griffin, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Differential single- versus double-strand DNA breakage produced by doxorubicin and its morpholinyl analoguesG E Duran, D H Lau, A D Lewis, et al.
British Journal of Cancer|February 12, 1998
The relationship between tumour oxygenation determined by oxygen electrode measurements and magnetic resonance spectroscopy of the fluorinated 2-nitroimidazole SR-4554E O Aboagye, R J Maxwell, M R Horsman, et al.
Anti-Cancer Drug Design|April 1, 1996
The pharmacokinetics, bioavailability and biodistribution in mice of a rationally designed 2-nitroimidazole hypoxia probe SR-4554E O Aboagye, A D Lewis, M A Graham, et al.
International Journal of Cancer|October 1, 1994
Differential intracellular processing of the anthracycline drug ME2303 in doxorubicin-sensitive (A2780) and -resistant (A2780AD) human ovarian cancer cells as studied with confocal laser scanning microscopy and image analysisI M Huxham, A L Barlow, A D Lewis, et al.
British Journal of Cancer|January 1, 1997
Involvement of DT-diaphorase (EC 1.6.99.2) in the DNA cross-linking and sequence selectivity of the bioreductive anti-tumour agent EO9S M Bailey, M D Wyatt, F Friedlos, et al.
British Journal of Cancer|January 1, 1997
DT-diaphorase and cytochrome B5 reductase in human lung and breast tumoursA Marín, A López de Cerain, E Hamilton, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Biochemical Pharmacology|October 23, 1998
Reduction of the indoloquinone anticancer drug EO9 by purified DT-diaphorase: a detailed kinetic study and analysis of metabolitesS M Bailey, A D Lewis, R J Knox, et al.
Biochemical Pharmacology|July 13, 2001
Involvement of NADPH: cytochrome P450 reductase in the activation of indoloquinone EO9 to free radical and DNA damaging speciesS M Bailey, A D Lewis, L H Patterson, et al.
Biochemical Society Transactions|August 1, 1987
The role of glutathione in determining the response of normal and tumor cells to anticancer drugsC R Wolf, A D Lewis, J Carmichael, et al.
The Journal of Biological Chemistry|April 5, 1987
Induction and suppression of glutathione transferases by interferon in the mouseD J Adams, F R Balkwill, D B Griffin, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Differential single- versus double-strand DNA breakage produced by doxorubicin and its morpholinyl analoguesG E Duran, D H Lau, A D Lewis, et al.
British Journal of Cancer|February 12, 1998
The relationship between tumour oxygenation determined by oxygen electrode measurements and magnetic resonance spectroscopy of the fluorinated 2-nitroimidazole SR-4554E O Aboagye, R J Maxwell, M R Horsman, et al.
Anti-Cancer Drug Design|April 1, 1996
The pharmacokinetics, bioavailability and biodistribution in mice of a rationally designed 2-nitroimidazole hypoxia probe SR-4554E O Aboagye, A D Lewis, M A Graham, et al.
International Journal of Cancer|October 1, 1994
Differential intracellular processing of the anthracycline drug ME2303 in doxorubicin-sensitive (A2780) and -resistant (A2780AD) human ovarian cancer cells as studied with confocal laser scanning microscopy and image analysisI M Huxham, A L Barlow, A D Lewis, et al.
British Journal of Cancer|January 1, 1997
Involvement of DT-diaphorase (EC 1.6.99.2) in the DNA cross-linking and sequence selectivity of the bioreductive anti-tumour agent EO9S M Bailey, M D Wyatt, F Friedlos, et al.
British Journal of Cancer|January 1, 1997
DT-diaphorase and cytochrome B5 reductase in human lung and breast tumoursA Marín, A López de Cerain, E Hamilton, et al.
Pageof 6